Category : Search result: pharmaceutical stocks


Gold Miners' Share Price Records Tumble

Leading gold miners including Newmont, Greatland Gold, and Capricorn Metals see share prices fall sharply. Discover the market forces and analyst insights behind the plunge.

WA Lithium Stocks Soar $2.8bn on Renewed Demand

Western Australia's top lithium stocks surged $2.8 billion in value on Tuesday, driven by a sharp price recovery and strong demand for battery metals. Discover the key players and market forces.

ASX Underperforms Global Peers in 2025

The Australian share market delivered a subdued performance in 2025, trailing major global indices. Discover the key factors behind the ASX's lag and what it means for investors.

High-security Perth cocaine production site sold

A unique Perth industrial property, where liquid cocaine is legally made for surgery, has sold for a multi-million dollar sum. The pharmaceutical tenant remains. Read the exclusive details.

WA Gold Miners Lead ASX Gains in 2025

Western Australian gold stocks have dominated the ASX200's best performers in 2025, delivering average gains of 159.5% as bullion soars. Discover the top companies and market outlook for 2026.

Mum's fight for Crohn's biologics access for sons

A Kambah mother fights for PBS reform so her sons with Crohn's can access biologics, a first-line treatment in other OECD nations, instead of 18 tablets daily. #Health #Crohns #Australia

Population Boom Threatens WA Fish Stocks

Western Australia's rapid population growth is putting unprecedented pressure on fish stocks. Industry leader Trevor Whittington warns of potential decimation without immediate action.

Alvo Minerals surges 178% on Brazilian copper find

Brazilian copper explorer Alvo Minerals rockets 178% after hitting massive sulphides just 40m below surface. Discover why this junior miner leads our ASX runners in a volatile market week.

Billionaire increases stake in Venus Metals

QCoal founder Chris Wallin quietly increases Venus Metals stake to 26.21% as the company's exposure to Youanmi gold project and royalty stream gains momentum. Discover the strategic moves.

Woman needs $500k drug for rare disease CTX

Dominique Roth battles rare CTX disease but the life-changing drug costs $500,000 annually. Her story highlights urgent need for PBS reforms to help Australians with rare conditions.

Page 1 of 2